These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3749402)

  • 41. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract]   [Full Text] [Related]  

  • 42. DST in depression is unaffected by altering the clock time of its administration.
    Pepper GM; Davis KL; Davis BM; Krieger DT
    Psychiatry Res; 1983 Feb; 8(2):105-9. PubMed ID: 6574528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adrenocorticotropin and cortisol response to lysine vasopressin in relation to the outcome of the dexamethasone suppression test in major depressive disorder.
    Akner G; Ljunggren JG; Kjellman BF; Undén F; Wetterberg L
    Acta Psychiatr Scand; 1988 Apr; 77(4):404-10. PubMed ID: 2839010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
    Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1985; 10(3):281-8. PubMed ID: 4059475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preliminary study of the dexamethasone suppression test in endogenous depression].
    Omori T; Denda K; Koyama T; Matsubara S; Yasuda M
    Seishin Shinkeigaku Zasshi; 1983; 85(11):816-9. PubMed ID: 6677917
    [No Abstract]   [Full Text] [Related]  

  • 46. The effects of weight change on the dexamethasone suppression test in depressed and anorexic patients.
    Schweitzer I; Maguire KP; Tiller JW; Gee AH; Harrison LC; Davies BM
    Br J Psychiatry; 1986 Dec; 149():751-5. PubMed ID: 3790873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disregulation of hypothalamic-pituitary-adrenal axis in the mentally retarded.
    Sandman CA; Barron JL; Parker L
    Pharmacol Biochem Behav; 1985 Jul; 23(1):21-6. PubMed ID: 4034619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease.
    Hatzinger M; Z'Brun A; Hemmeter U; Seifritz E; Baumann F; Holsboer-Trachsler E; Heuser IJ
    Neurobiol Aging; 1995; 16(2):205-9. PubMed ID: 7777138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A; Taneli B; Sivrioğlu Y
    Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test.
    Schweitzer I; Maguire KP; Gee AH; Tiller JW; Biddle N; Davies B
    Br J Psychiatry; 1987 Dec; 151():780-4. PubMed ID: 3502804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dysregulation of hypothalamic-pituitary-adrenal axis function in depressed alcoholic patients.
    Targum SD; Wheadon DE; Chastek CT; McCabe WJ; Advani MT
    J Affect Disord; 1982 Dec; 4(4):347-53. PubMed ID: 6219148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced adrenal sensitivity to exogenous cosyntropin (ACTH alpha 1-24) stimulation in major depression. Relationship to dexamethasone suppression test results.
    Jaeckle RS; Kathol RG; Lopez JF; Meller WH; Krummel SJ
    Arch Gen Psychiatry; 1987 Mar; 44(3):233-40. PubMed ID: 3030218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE; Parker L; Pawlarczyk D; Couk DI; Schumacher KS; Yearwood K
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients.
    Roy M; Collier B; Roy A
    Psychiatry Res; 1990 Jan; 31(1):31-7. PubMed ID: 2156275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.
    Axelson DA; Doraiswamy PM; Boyko OB; Rodrigo Escalona P; McDonald WM; Ritchie JC; Patterson LJ; Ellinwood EH; Nemeroff CB; Krishnan KR
    Psychiatry Res; 1992 Oct; 44(1):63-70. PubMed ID: 1461948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
    Nelson WH; Orr WW; Stevenson JM; Shane SR
    Arch Gen Psychiatry; 1982 Sep; 39(9):1033-6. PubMed ID: 7115012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Major depressive episode and low dose dexamethasone suppression test.
    Sarai M; Taniguchi N; Kagomoto T; Kameda H; Uema T; Hishikawa Y
    Folia Psychiatr Neurol Jpn; 1982; 36(2):109-14. PubMed ID: 7129257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Occurrence of high concentrations of postdexamethasone cortisol in elderly psychiatric inpatients.
    Fogel BS; Satel SL; Levy S
    Psychiatry Res; 1985 Jun; 15(2):85-90. PubMed ID: 3862149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre- and post-dexamethasone salivary cortisol concentrations in major depression.
    Copolov DL; Rubin RT; Mander AJ; Sashidharan SP; Whitehouse AM; Blackburn IM; Freeman CP; Blackwood DH; Lane LA; Poland RE
    Psychoneuroendocrinology; 1985; 10(4):461-7. PubMed ID: 4089085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL; Nemeroff CB; Haggerty JJ; Pedersen CA
    Psychoneuroendocrinology; 1987; 12(3):203-9. PubMed ID: 3615749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.